BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20028976)

  • 1. Targets of the Tal1 transcription factor in erythrocytes: E2 ubiquitin conjugase regulation by Tal1.
    Lausen J; Pless O; Leonard F; Kuvardina ON; Koch B; Leutz A
    J Biol Chem; 2010 Feb; 285(8):5338-46. PubMed ID: 20028976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells.
    Kassouf MT; Hughes JR; Taylor S; McGowan SJ; Soneji S; Green AL; Vyas P; Porcher C
    Genome Res; 2010 Aug; 20(8):1064-83. PubMed ID: 20566737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis.
    Ravet E; Reynaud D; Titeux M; Izac B; Fichelson S; Roméo PH; Dubart-Kupperschmitt A; Pflumio F
    Blood; 2004 May; 103(9):3326-35. PubMed ID: 14715640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitination and degradation of Tal1/SCL are induced by notch signaling and depend on Skp2 and CHIP.
    Nie L; Wu H; Sun XH
    J Biol Chem; 2008 Jan; 283(2):684-92. PubMed ID: 17962192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation.
    Condorelli G; Vitelli L; Valtieri M; Marta I; Montesoro E; Lulli V; Baer R; Peschle C
    Blood; 1995 Jul; 86(1):164-75. PubMed ID: 7540882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation.
    Kuvardina ON; Herglotz J; Kolodziej S; Kohrs N; Herkt S; Wojcik B; Oellerich T; Corso J; Behrens K; Kumar A; Hussong H; Urlaub H; Koch J; Serve H; Bonig H; Stocking C; Rieger MA; Lausen J
    Blood; 2015 Jun; 125(23):3570-9. PubMed ID: 25911237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
    Patel B; Kang Y; Cui K; Litt M; Riberio MS; Deng C; Salz T; Casada S; Fu X; Qiu Y; Zhao K; Huang S
    Leukemia; 2014 Feb; 28(2):349-61. PubMed ID: 23698277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of basic helix-loop-helix protein-containing complexes during erythroid differentiation.
    Lister JA; Baron MH
    Gene Expr; 1998; 7(1):25-38. PubMed ID: 9572395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors.
    Cai Y; Xu Z; Xie J; Ham AJ; Koury MJ; Hiebert SW; Brandt SJ
    Biochem Biophys Res Commun; 2009 Dec; 390(2):295-301. PubMed ID: 19799863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells.
    Valge-Archer VE; Osada H; Warren AJ; Forster A; Li J; Baer R; Rabbitts TH
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8617-21. PubMed ID: 8078932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor SCL/TAL1 mediates the phosphorylation of MEK/ERK pathway in umbilical cord blood CD34⁺ stem cells during hematopoietic differentiation.
    Zhou RQ; Wu JH; Gong YP; Guo Y; Xing HY
    Blood Cells Mol Dis; 2014; 53(1-2):39-46. PubMed ID: 24405580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splicing factor SF3B1K700E mutant dysregulates erythroid differentiation via aberrant alternative splicing of transcription factor TAL1.
    Jin S; Su H; Tran NT; Song J; Lu SS; Li Y; Huang S; Abdel-Wahab O; Liu Y; Zhao X
    PLoS One; 2017; 12(5):e0175523. PubMed ID: 28545085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired in vitro erythropoiesis following deletion of the Scl (Tal1) +40 enhancer is largely compensated for in vivo despite a significant reduction in expression.
    Ferreira R; Spensberger D; Silber Y; Dimond A; Li J; Green AR; Göttgens B
    Mol Cell Biol; 2013 Mar; 33(6):1254-66. PubMed ID: 23319051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages.
    Palii CG; Perez-Iratxeta C; Yao Z; Cao Y; Dai F; Davison J; Atkins H; Allan D; Dilworth FJ; Gentleman R; Tapscott SJ; Brand M
    EMBO J; 2011 Feb; 30(3):494-509. PubMed ID: 21179004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral-mediated knockdown during ex vivo erythropoiesis of human hematopoietic stem cells.
    Palii CG; Pasha R; Brand M
    J Vis Exp; 2011 Jul; (53):. PubMed ID: 21785407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modular UBE2H-CTLH E2-E3 complexes regulate erythroid maturation.
    Sherpa D; Mueller J; Karayel Ö; Xu P; Yao Y; Chrustowicz J; Gottemukkala KV; Baumann C; Gross A; Czarnecki O; Zhang W; Gu J; Nilvebrant J; Sidhu SS; Murray PJ; Mann M; Weiss MJ; Schulman BA; Alpi AF
    Elife; 2022 Dec; 11():. PubMed ID: 36459484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
    Fujiwara T; Sasaki K; Saito K; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Harigae H
    Biochem Biophys Res Commun; 2017 Apr; 485(2):380-387. PubMed ID: 28216155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoforms of the TAL1 transcription factor have different roles in hematopoiesis and cell growth.
    Sharma A; Mistriel-Zerbib S; Najar RA; Engal E; Bentata M; Taqatqa N; Dahan S; Cohen K; Jaffe-Herman S; Geminder O; Baker M; Nevo Y; Plaschkes I; Kay G; Drier Y; Berger M; Salton M
    PLoS Biol; 2023 Jun; 21(6):e3002175. PubMed ID: 37379322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation.
    Steiner M; Schneider L; Yillah J; Gerlach K; Kuvardina ON; Meyer A; Maring A; Bonig H; Seifried E; Zörnig M; Lausen J
    PLoS One; 2019; 14(1):e0210515. PubMed ID: 30653565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta induces degradation of TAL1/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylation.
    Terme JM; Lhermitte L; Asnafi V; Jalinot P
    Blood; 2009 Jun; 113(26):6695-8. PubMed ID: 19406989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.